SPLICEBIO S.L.
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
SPLICEBIO
SPLICEBIO S.L.
Carrer Baldiri Reixac, 10- 12, (parc Científic Barcelona) 08028 Barcelona
https://splice.bio
SpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to develop the next generation of gene therapies. The Company's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by adeno-associated viral (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults.
Industries & Technologies
Financial data
Other information
Funding
50M € (February 2022)
Minority stake unknown %
Investors: UCE Ventures, Ysios Capital, New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, Sabadell Asabys
1.7M € (March 2018)
Minority stake unknown %
Investors: CAIXA CAPITAL RISC, PRIVATE BUSINESS ANGEL
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
@ProteoDesignHQ
Other startups near startup SPLICEBIO
similar companies
- Healthtech
- Omic Sciences
- Vaccines & New biological design
- Biotechnology
- Personalized medicine
- Deeptech
- Healthtech
- Vaccines & New biological design
- Biotechnology
- Personalized medicine
- Deeptech
- Scaleup
- Healthtech
- Vaccines & New biological design
- Biotechnology
- Personalized medicine
- Deeptech
- Scaleup
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.